JOURNAL OF THE CZECH PHARMACEUTICAL SOCIETY AND THE SLOVAK PHARMACEUTICAL SOCIETY

Čes. slov. farm. 2008, 57(1):21-27

A study of the properties of tablets made of directly compressible maltose

J. Mužíková*, J. Balhárková
Charles University in Prague, Faculty of Pharmacy in Hradec Králové, Czech Republic, Department of Pharmaceutical Technology

The paper deals with the study of the strength and disintegration time of tablets made of directly compressible maltose Advantose 100. It studies the differences of the effects of two types of lubricants, magnesium stearate and sodium stearylfumarate, on the above-mentioned properties, and it also tests the mixtures of the substance with microcrystalline cellulose Vivapur 102 in a ratio of 1:1 and with ascorbic and acetylsalicylic acids. The compacts are obtained by using three compression forces, excepting mixtures with active ingredients, where one compression force is used. In the compression forces of 6 and 8 kN, no statistically significant difference was found in the intervention of the lubricants into the strength of the compacts made of Advantose 100, only in the compression force of 10 kN Pruv decreased the strength more than stearate. The mixture of Advantose 100 and Vivapur 102 yielded the strongest tablets, an addition of Pruv to it decreased the strength of compacts more than stearate. The periods of disintegration time of Advantose compacts as well as those of the mixture of dry binders were longer with an addition of Pruv. The compacts with acetylsalicylic acid possessed higher strength and a longer period of disintegration than those with ascorbic acid. There was no statistically significant difference within the type of the lubricant employed, both in the case of Advantose 100 and its mixture with Vivapur 102, between the values of strength of the compacts with acetylsalicylic acid.

Keywords: Advantose 100; Vivapur 102; lubricants; tensile strength of tablets; time of disintegration
Grants and funding:

The study was supported by the grant MSM 0021620822 and by the firms SPI Pharma group and J. Rettenmaier & Söhne GmbH + Co, which supplied the samples of the dry binders tested.

Received: December 6, 2007; Accepted: December 20, 2007; Published: January 1, 2008  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Mužíková J, Balhárková J. A study of the properties of tablets made of directly compressible maltose. Čes. slov. farm. 2008;57(1):21-27.
Download citation

References

  1. Bolhuis, G. K., Armstrong, N. A.: Pharm. Dev. Technol., 2006; 11, 111-124. Go to original source... Go to PubMed...
  2. Kibbe, H. A.: Handbook of pharmaceutical excipients. Third ed., American Pharmaceutical Association and the Pharmaceutical Press, Washington, London, 2000, 175-177.
  3. SPI Pharma group: Advantose™ 100 Maltose Powder for Direct Compression. Firm. Lit., http://www.spipharma.com/ProductsFolder/104Maltose/104Maltose100.html, April 2007.
  4. Bowe, K. E., Bilig, J. L., Schwartz, J. B. et al.: Pharm. Technol. Eur., 1998; 10,5, 34-40. Go to original source...
  5. Fell, J. T., Newton, J. M.: J. Pharm. Sci., 1970; 59, 5, 688-691. Go to original source... Go to PubMed...
  6. Bos, C. E., Bolhuis, H., Van Doorne, Lerk, C. F.: Pharm. Weekbl.,1987; Sci. Ed. 9, 274-282. Go to original source... Go to PubMed...
  7. Ph.B. MMV, Grada Publishing, a.s., Prague, 2005, vol. I, s. 269.
  8. Belousov, V. A.: Khim. Farm. Zh., 1976; 10, 105-111. Go to original source...
  9. Jarosz, P. J., Parrott, E. L.: Drug Dev. Ind. Pharm., 1984; 10(2), 259-273. Go to original source...
  10. Bolhuis, G. K.; Chowhan, Z. T.: In: Pharmaceutical Powder Compaction Technology; (Alderborn, G.; Nyström, Ch.), New York - Basel - Hongkong, Marcel Dekker 1996, 491-493.




Czech and Slovak Pharmacy

Madam, Sir,
please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

I declare:

  1. that I have met the above instruction
  2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited


No

Yes

If your statement is not true, please be aware
that brings the risk of danger to their health or the health of others.